Home/Filings/4/0000874716-25-000170
4//SEC Filing

Peacock Karen 4

Accession 0000874716-25-000170

CIK 0000874716other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 5:01 PM ET

Size

8.1 KB

Accession

0000874716-25-000170

Insider Transaction Report

Form 4
Period: 2025-12-01
Transactions
  • Award

    Restricted Stock Unit

    2025-12-01+101101 total
    Common Stock (101 underlying)
  • Award

    Non-Qualified Stock Option (right-to-buy)

    2025-12-01+231231 total
    Exercise: $727.97Exp: 2035-11-30Common Stock (231 underlying)
Footnotes (3)
  • [F1]This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from the date of her election to the IDEXX Laboratories, Inc. Board of Directors on October 6, 2025 until the 2026 annual meeting of stockholders.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock and vest in one installment on May 7, 2026 or on the date of the 2026 annual meeting of stockholders, whichever event is earlier.
  • [F3]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests in one installment on May 7, 2026 or on the date of the 2026 annual meeting of stockholders, whichever event is earlier.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001786299

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:01 PM ET
Size
8.1 KB